Nicotine enhances responding with conditioned reinforcement.

Peter Olausson, J David Jentsch, Jane R Taylor
Author Information
  1. Peter Olausson: Department of Psychiatry, Laboratory of Molecular Psychiatry, Yale University, 34 Park Street, New Haven, CT 06508, USA.

Abstract

RATIONALE: The mesolimbic dopamine system has been implicated in the primary reinforcing properties of drugs of abuse as well as in enhanced responding with conditioned reinforcement produced by psychomotor stimulant drugs. Despite clinical observations that nicotine self-administration (i.e. smoking) depends strongly upon conditioned reinforcement (i.e. cues support smoking behavior), little is known about whether nicotine directly affects motivational processes.
OBJECTIVE: In these experiments, we investigated whether acute nicotine would influence responding with conditioned reinforcement and the degree to which pretreatment with the nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine would modify any nicotine-induced behavioral effects.
METHODS: After subjects had been trained to associate an initially neutral stimulus with water reward, they received acute nicotine (43,25-350 micro g/kg SC; -5 min) or saline injections and were tested on the acquisition of a new response for conditioned reinforcement paradigm. In separate experiments, the effect of pretreatment with the nicotinic acetylcholine receptor antagonist mecamylamine (300 or 1000 micro g/kg SC; -20 min) alone, or in combination with nicotine (350 micro g/kg SC; -5 min), on conditioned reinforcement was also examined.
RESULTS: Acute nicotine injection produced a selective enhancement of responding with conditioned reinforcement (i.e. on the CR lever), without producing non-selective increases in overall responding. The effect of nicotine (350 micro g/kg SC; -5 min) was selectively blocked by mecamylamine (300 micro g/kg).
CONCLUSIONS: These findings demonstrate that acute exposure to nicotine augments the control over behavior by a conditioned reinforcer, suggesting that nicotine may enhance motivational processes.

References

  1. Addiction. 1999 Mar;94(3):327-40 [PMID: 10605857]
  2. Neurosci Biobehav Rev. 1989 Summer-Fall;13(2-3):155-62 [PMID: 2682402]
  3. Psychopharmacology (Berl). 1999 Feb;142(1):31-40 [PMID: 10102780]
  4. Br J Addict. 1991 May;86(5):605-9 [PMID: 1859927]
  5. J Psychopharmacol. 1998;12(1):15-22 [PMID: 9584964]
  6. Nature. 1996 Jul 18;382(6588):255-7 [PMID: 8717040]
  7. Trends Pharmacol Sci. 1992 May;13(5):177-84 [PMID: 1604710]
  8. Psychopharmacology (Berl). 1986;90(3):390-7 [PMID: 3097729]
  9. J Neurosci. 2002 May 1;22(9):3312-20 [PMID: 11978805]
  10. Brain Res Brain Res Rev. 2001 Oct;36(2-3):129-38 [PMID: 11690609]
  11. Neuron. 2000 Mar;25(3):515-32 [PMID: 10774721]
  12. Pharmacol Rev. 2002 Mar;54(1):1-42 [PMID: 11870259]
  13. J Psychopharmacol. 1998;12(1):23-30 [PMID: 9584965]
  14. Psychopharmacology (Berl). 1991;103(2):187-96 [PMID: 2027920]
  15. Psychopharmacology (Berl). 1983;80(2):113-9 [PMID: 6136060]
  16. Pharmacol Biochem Behav. 2000 Feb;65(2):247-54 [PMID: 10672976]
  17. Addiction. 2000 Aug;95 Suppl 2:S91-117 [PMID: 11002906]
  18. Addict Behav. 2000 Jan-Feb;25(1):103-8 [PMID: 10708324]
  19. Am J Psychiatry. 2002 Jun;159(6):954-60 [PMID: 12042183]
  20. Pharmacol Biochem Behav. 2001 Dec;70(4):515-30 [PMID: 11796151]
  21. Psychopharmacology (Berl). 1999 Nov;147(2):210-6 [PMID: 10591889]
  22. Nat Rev Neurosci. 2001 Oct;2(10):695-703 [PMID: 11584307]
  23. Psychopharmacology (Berl). 1991;103(2):197-203 [PMID: 1709289]
  24. Behav Brain Res. 2000 Aug;113(1-2):73-83 [PMID: 10942034]
  25. Acta Physiol Scand. 1988 Aug;133(4):595-6 [PMID: 3147576]
  26. Psychopharmacology (Berl). 1984;84(3):405-12 [PMID: 6440188]
  27. Am J Psychiatry. 1999 Jan;156(1):11-8 [PMID: 9892292]
  28. Can J Physiol Pharmacol. 1998 Mar;76(3):259-68 [PMID: 9673789]
  29. Cereb Cortex. 2000 Mar;10(3):318-25 [PMID: 10731226]
  30. Drug Alcohol Depend. 1998 Jan 1;49(2):95-104 [PMID: 9543646]
  31. J Neural Transm (Vienna). 1997;104(1):1-10 [PMID: 9085189]
  32. Physiol Rev. 1991 Jan;71(1):155-234 [PMID: 1986388]
  33. Psychopharmacology (Berl). 1991;104(3):377-85 [PMID: 1924645]
  34. J Neurosci. 2002 May 1;22(9):3306-11 [PMID: 11978804]
  35. Psychopharmacology (Berl). 1994 Mar;114(2):345-59 [PMID: 7838928]
  36. Psychopharmacology (Berl). 1999 Oct;146(4):373-90 [PMID: 10550488]
  37. Addict Behav. 1989;14(4):419-28 [PMID: 2782124]
  38. Brain Res. 1992 Aug 14;588(1):104-14 [PMID: 1327405]
  39. Brain Res. 1987 Jan 20;401(2):322-30 [PMID: 3815099]
  40. Psychopharmacology (Berl). 1993;112(2-3):163-82 [PMID: 7871016]
  41. Pharmacol Biochem Behav. 2002 Mar;71(3):517-29 [PMID: 11830186]
  42. Neuropsychopharmacology. 1999 Mar;20(3):297-307 [PMID: 10063490]
  43. J Neurosci. 1999 Mar 15;19(6):2401-11 [PMID: 10066290]
  44. Psychopharmacology (Berl). 1994 Aug;115(4):516-28 [PMID: 7871097]
  45. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8 [PMID: 2899326]
  46. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):12040-5 [PMID: 8876259]
  47. Synapse. 2000 Jun 15;36(4):314-21 [PMID: 10819909]
  48. Prog Neurobiol. 1980;14(2-3):69-97 [PMID: 6999537]
  49. Brain Res. 1994 Aug 8;653(1-2):278-84 [PMID: 7982062]
  50. Neuropsychopharmacology. 2003 Jul;28(7):1264-71 [PMID: 12700688]
  51. Nature. 1999 Apr 15;398(6728):567-70 [PMID: 10217139]
  52. Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91 [PMID: 8401595]
  53. Psychopharmacology (Berl). 1999 Dec;147(3):306-13 [PMID: 10639690]

Grants

  1. DA 11717/NIDA NIH HHS
  2. DA 13334/NIDA NIH HHS

MeSH Term

Animals
Conditioning, Classical
Discrimination Learning
Dose-Response Relationship, Drug
Drug Synergism
Male
Mecamylamine
Nicotine
Nicotinic Agonists
Rats
Rats, Sprague-Dawley
Reinforcement, Psychology

Chemicals

Nicotinic Agonists
Mecamylamine
Nicotine

Word Cloud

Created with Highcharts 10.0.0nicotineconditionedreinforcementrespondingmicrog/kgSCminieacutemecamylamine-5drugsproducedsmokingbehaviorwhethermotivationalprocessesexperimentspretreatmentnicotinicacetylcholinereceptorantagonisteffect300350RATIONALE:mesolimbicdopaminesystemimplicatedprimaryreinforcingpropertiesabusewellenhancedpsychomotorstimulantDespiteclinicalobservationsself-administrationdependsstronglyuponcuessupportlittleknowndirectlyaffectsOBJECTIVE:investigatedinfluencedegreenAChRmodifynicotine-inducedbehavioraleffectsMETHODS:subjectstrainedassociateinitiallyneutralstimuluswaterrewardreceived4325-350salineinjectionstestedacquisitionnewresponseparadigmseparate1000-20alonecombinationalsoexaminedRESULTS:AcuteinjectionselectiveenhancementCRleverwithoutproducingnon-selectiveincreasesoverallselectivelyblockedCONCLUSIONS:findingsdemonstrateexposureaugmentscontrolreinforcersuggestingmayenhanceNicotineenhances

Similar Articles

Cited By